Salvadó, IriaGamba, IlariaMontenegro García, JavierMartínez Costas, José ManuelBrea Floriani, José ManuelLoza García, María IsabelVázquez López, MiguelVázquez Sentís, Marco Eugenio2017-09-152017-09-152016-08-19Salvadó, I, Gamba, I, Montenegro J, Martínez-Costas J, Brea JM, Loza MI, Vázquez López M, Vázquez M.E. Membrane-disrupting iridium(III) oligocationic organometallopeptides. Chem. Commun., 2016,52, 11008-11011. DOI: 10.1039/C6CC05537K1359-7345http://hdl.handle.net/10347/15772NOTICE: This is the peer reviewed version of the following article: Salvadó, I, Gamba, I, Montenegro J, Martínez-Costas J, Brea JM, Loza MI, Vázquez López M, Vázquez M.E. Membrane-disrupting iridium(III) oligocationic organometallopeptides. Chem. Commun., 2016,52, 11008-11011. DOI: 10.1039/C6CC05537K. This article may be used for non-commercial purposes in accordance with RSC Terms and Conditions for self-archivingA series of oligoarginine peptide derivatives containing cyclometallated iridium(III) units display remarkable cytotoxicity, comparable to that of cisplatin. In vitro studies with unilamellar vesicles support a membrane-disrupting mechanism of actioneng© The Royal Society of Chemistry 2016journal article10.1039/C6CC05537K1364-548Xopen access